Evidence map›Paper›PMID 17093193›Full record

ArticleJournal of virology2007

Loss of naïve cells accompanies memory CD4+ T-cell depletion during long-term progression to AIDS in Simian immunodeficiency virus-infected macaques.

Yoshiaki Nishimura, Tatsuhiko Igarashi, Alicia Buckler-White, Charles Buckler, Hiromi Imamichi, Robert M Goeken, Wendy R Lee, Bernard A P Lafont, Russ Byrum, H Clifford Lane and 2 more

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Memory T cells in Rhesus macaques.Advances in experimental medicine and biology · 2010
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Yoshiaki NishimuraLaboratory of Molecular Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Tatsuhiko Igarashi
Alicia Buckler-White
Charles Buckler
Hiromi Imamichi
Robert M Goeken
Wendy R Lee
Bernard A P Lafont
Russ Byrum
H Clifford Lane
Vanessa M Hirsch
Malcolm A Martin
Laboratory of Molecular Genetics · PLBioqual · USNational Institute of Allergy and Infectious Diseases · USScience Applications International Corporation (United States) · US

Funding

Pathogenesis and Treatment of HIV InfectionZIAAI000585 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI LANE, CLIFFORD · 2009 to 2025
$26.8M
Pathogenesis Studies Of Simian Immunodeficiency Virus Infection Of MonkeysZIAAI000370 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI HIRSCH, VANESSA M. · 2009 to 2022
$16.2M
Primate Lentivirus PathogenesisZIAAI000998 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI MARTIN, MALCOLM · 2009 to 2015
$11.3M
Molecular Biology Of Retroviruses Associated With AIDSZIAAI000415 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI MARTIN, MALCOLM · 2009 to 2015
$11.3M
MOLECULAR BIOLOGY OF RETROVIRUSES ASSOCIATED WITH AIDSZ01AI000415 · NIAID · NIAID EXTRAMURAL ACTIVITIES · PI MARTIN, MALCOLM · 1986 to 2008
$9.9M
STUDIES OF SIMIAN IMMUNODEFICIENCY VIRUS (SIV) INFECTION OF MACAQUESZ01AI000370 · NIAID · NIAID EXTRAMURAL ACTIVITIES · PI HIRSCH, VANESSA M. · 1985 to 2008
$5.6M
Primate Lentivirus PathogenesisZ01AI000998 · NIAID · NIAID EXTRAMURAL ACTIVITIES · PI MARTIN, MALCOLM · 2007 to 2008
$4.6M
PATHOGENIC MECHANISMS IN HUMAN IMMUNODEFICIENCY VIRUS INFECTIONSZ01AI000585 · NIAID · NIAID EXTRAMURAL ACTIVITIES · PI LANE, HENRY C · 1990 to 2008
$4.5M
6 · The paper itself

Abstract

Human immunodeficiency virus and simian immunodeficiency virus (SIV) induce a slow progressive disease, characterized by the massive loss of memory CD4+ T cells during the acute infection followed by a recovery phase in which virus replication is partially controlled. However, because the initial injury is so severe and virus production persists, the immune system eventually collapses and a symptomatic fatal disease invariably occurs. We have assessed CD4+ T-cell dynamics and disease progression in 12 SIV-infected rhesus monkeys for nearly 2 years. Three macaques exhibiting a rapid progressor phenotype experienced rapid and irreversible loss of memory, but not naïve, CD4+ T lymphocytes from peripheral blood and secondary lymphoid tissues and died within the first 6 months of virus inoculation. In contrast, SIV-infected conventional progressor animals sustained marked but incomplete depletions of memory CD4+ T cells and continuous activation/proliferation of this T-lymphocyte subset. This was associated with a profound loss of naïve CD4+ T cells from peripheral blood and secondary lymphoid tissues, which declined at rates that correlated with disease progression. These data suggest that the persistent loss of memory CD4(+)T cells, which are being eliminated by direct virus killing and activation-induced cell death, requires the continuous differentiation of naïve into memory CD4+ T cells. This unrelenting replenishment process eventually leads to the exhaustion of the naïve CD4+T-cell pool and the development of disease.

Indexed as

Immunologic MemoryAcute DiseaseAnimalsCD4 Lymphocyte CountCD4-Positive T-LymphocytesChronic DiseaseDisease ProgressionHumansMacaca mulattaRNA, ViralSimian Acquired Immunodeficiency SyndromeSimian Immunodeficiency VirusRNA, Viral

Identifiers

PMID17093193
PMCPMC1797457
OpenAlexW2104127225

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.